美股新聞 標題聯播 · 近 24 小時 305 則 · 28 個來源 · 最新 9/20 06:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · OMER近 30 天 2 則 · 第 1 / 1 頁
- What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now?
- Omeros (OMER) Just Flashed Golden Cross Signal: Do You Buy?
- Omeros (OMER) Q2 2026 Earnings Call Transcript
- Omeros (OMER) Turns Profitable As Investors Ask If The Repricing Has Gone Too Far
- This Biotech Stock Just Gapped Up To A Five-Year High; Here's Why
- Omeros Corporation Q2 2026 Earnings Call Summary
- Omeros Q2 Earnings Call Highlights
- Omeros (OMER) Q2 Earnings and Revenues Beat Estimates
- OMER Stock Soars 24% After-Hours On YARTEMLEA Sales Momentum, Debt Reduction And Share Buybacks
- Omeros Corporation Reports Second Quarter 2026 Financial Results
- Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
- OMER Stock Gains 4% — CMS Green-Lights $287K Add-On Payments For Transplant Drug
- CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®
- AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights
- Omeros (OMER) is Amongst The Best Names Under $10 That Could Yield More Than 200% Return
- Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
- Is Omeros Corporation (OMER) the Best Get Rich Quick Stock to Buy Right Now?
- Why Is OMER Stock Falling Today?
- Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。